ZA200002338B - Combination therapy for the treatment of migraine. - Google Patents

Combination therapy for the treatment of migraine.

Info

Publication number
ZA200002338B
ZA200002338B ZA200002338A ZA200002338A ZA200002338B ZA 200002338 B ZA200002338 B ZA 200002338B ZA 200002338 A ZA200002338 A ZA 200002338A ZA 200002338 A ZA200002338 A ZA 200002338A ZA 200002338 B ZA200002338 B ZA 200002338B
Authority
ZA
South Africa
Prior art keywords
migraine
treatment
combination therapy
therapy
combination
Prior art date
Application number
ZA200002338A
Other languages
English (en)
Inventor
George Harry Sands
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200002338B publication Critical patent/ZA200002338B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200002338A 1999-05-14 2000-05-12 Combination therapy for the treatment of migraine. ZA200002338B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13431299P 1999-05-14 1999-05-14

Publications (1)

Publication Number Publication Date
ZA200002338B true ZA200002338B (en) 2001-11-12

Family

ID=22462780

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200002338A ZA200002338B (en) 1999-05-14 2000-05-12 Combination therapy for the treatment of migraine.

Country Status (11)

Country Link
US (1) US20050101653A1 (ja)
EP (1) EP1051995A3 (ja)
JP (1) JP2000344667A (ja)
KR (1) KR20010029716A (ja)
AU (1) AU3406500A (ja)
CA (1) CA2308826A1 (ja)
CO (1) CO5261541A1 (ja)
HU (1) HUP0001891A3 (ja)
IL (1) IL136025A0 (ja)
PE (1) PE20010128A1 (ja)
ZA (1) ZA200002338B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
DE69922688T2 (de) 1998-11-02 2005-12-01 Merck & Co. Inc. Zusammensetzungen aus einem 5ht1b/1d agonisten und einem selektiven cox-2 hemmer zur behandlung von migräne
GB9929039D0 (en) * 1999-12-08 2000-02-02 Glaxo Group Ltd Medicaments
EP1575566B1 (en) 2002-12-26 2012-02-22 Pozen, Inc. Multilayer dosage forms containing naproxen and triptans
MXPA05010070A (es) * 2003-04-11 2005-11-23 Pfizer Combinacion farmaceutica.
CN102088966B (zh) 2008-06-20 2015-06-10 阿尔法制药有限公司 药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5286843A (en) * 1992-05-22 1994-02-15 Rohm And Haas Company Process for improving water-whitening resistance of pressure sensitive adhesives
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
KR100229343B1 (ko) * 1993-11-30 1999-11-01 윌리암스 로저 에이 염증치료용 치환 피라졸일벤젠술폰아미드
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5691374A (en) * 1995-05-18 1997-11-25 Merck Frosst Canada Inc. Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
US5861419A (en) * 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US5994379A (en) * 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use

Also Published As

Publication number Publication date
CO5261541A1 (es) 2003-03-31
HUP0001891A3 (en) 2003-07-28
AU3406500A (en) 2000-11-16
EP1051995A3 (en) 2003-01-08
HU0001891D0 (en) 2000-07-28
EP1051995A2 (en) 2000-11-15
US20050101653A1 (en) 2005-05-12
JP2000344667A (ja) 2000-12-12
IL136025A0 (en) 2001-05-20
KR20010029716A (ko) 2001-04-16
CA2308826A1 (en) 2000-11-14
HUP0001891A2 (en) 2001-03-28
PE20010128A1 (es) 2001-02-28

Similar Documents

Publication Publication Date Title
EP1446012A4 (en) Bacteriolytic combination therapy for the treatment of tumors
IL196301A0 (en) Medicament for the treatment of hapatitis c
HK1047284A1 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
IL158329A0 (en) Antiangiogenic combination therapy for the treatment of cancer
HUP0500424A2 (en) Combination therapy for the treatment of cancer
ZA200003236B (en) Combination therapy for the treatment of migraine.
IL146697A0 (en) SELECTIVE iGluR5 RECEPTOR FOR THE TREATMENT OF MIGRAINE
ZA200202822B (en) Oncolytic combinations for the treatment of cancer.
HK1040184A1 (zh) 治療青光眼之組合療法
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
HK1047048A1 (en) Therapeutic use of melatonin.
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
HUP0101947A3 (en) Combination for the treatment of tumors
AU2001285156A1 (en) Combination therapy for the treatment of migraine
ZA200003235B (en) Combination therapy for the treatment of migraine.
ZA200002338B (en) Combination therapy for the treatment of migraine.
ZA200002343B (en) Combination therapy for the treatment of migraine.
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
ZA200203166B (en) Treatment of cancer.
HK1050533A1 (en) Substituted pyrroles as antiproliferative agents for the treatment of cancer.
ZA991786B (en) Therapeutic treatment for asthma.
PT1451177E (pt) Derivados substituídos de 2-pirrolidin-2-1l-1h-indole para o tratamento da enxaqueca.
HK1042039A1 (en) Use of phanquinone for the treatment or preventionof memory impairment.
ZA200408071B (en) Combination therapy for the treatment of cancer.